Arena Pharmaceuticals, Inc.

Press Releases



All Releases

View Summary Arena Pharmaceuticals Issued Patent for APD371 by United States Patent and Trademark Office
Jul 15, 2014
PDF 11.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals Reports that Eisai Completes Planned Increase in Sales Force for BELVIQ® (lorcaserin HCl) CIV
Jul 10, 2014
PDF 16.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 2014 Wells Fargo Securities Healthcare Conference
Jun 13, 2014
PDF 10.5 KB Add to Briefcase
View Summary Lorcaserin HCl Data to be Presented at American Diabetes Association's 74th Scientific Sessions
Jun 9, 2014
PDF 49.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Initiates Phase 1b Clinical Trial of APD334 for Autoimmune Diseases
Jun 3, 2014
PDF 11.3 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference
May 27, 2014
PDF 10.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2014 Financial Results
May 12, 2014
PDF 21.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Reports that Eisai Plans to Further Increase its Sales Force for BELVIQ® (lorcaserin HCl) CIV by 50%
May 9, 2014
PDF 17.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, May 12
May 5, 2014
PDF 10.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Reports Eisai's Launch of National Television Advertising Campaign for BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management
Apr 14, 2014
PDF 17.8 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2013 Financial Results
Feb 27, 2014
PDF 26.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Provide Corporate Update and Report Financial Results on Thursday, February 27
Feb 20, 2014
PDF 10.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Filing for Marketing Authorization of BELVIQ® (lorcaserin HCl) in Brazil
Feb 12, 2014
PDF 63.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals Reports Coverage for BELVIQ® (lorcaserin HCl) CIV Now Greater Than 50% of Insured Commercial Lives
Feb 10, 2014
PDF 16.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
Feb 5, 2014
PDF 10.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 6, 2014
PDF 10.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
Nov 27, 2013
PDF 10.2 KB Add to Briefcase
View Summary BELVIQ® (lorcaserin HCl) CIV Data to be Presented at American Heart Association 2013 Scientific Sessions
Nov 18, 2013
PDF 18.6 KB Add to Briefcase
View Summary BELVIQ® (lorcaserin HCl) CIV Data Featured in Five Abstracts to be Presented at ObesityWeek(SM) 2013
Nov 13, 2013
PDF 20.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
Nov 7, 2013
PDF 24.7 KB Add to Briefcase
Showing 21-40 of 470 Page: 1 2 3 4 5 6 ... 24  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase